Jakob Begun

Jakob Begun

Auto-generated profile, based on publicly available information

Jakob Begun

Department of Gastroenterology Mater Hospital Brisbane Australia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2003 in Science
Verified
Journal Article
Closed access
PDF file
DGDanielle A. Garsin
Danielle A. Garsin
JVJacinto M. Villanueva
Jacinto M. Villanueva
JBJakob Begun
Jakob Begun
DKDennis H. Kim
Dennis H. Kim
CSCosti D. Sifri
Costi D. Sifri
FAFrederick M. Ausubel
Frederick M. Ausubel

28 June 2016 in Scientific Reports
Verified
Journal Article
Open access
MGMax Gulhane
Max Gulhane
LMLydia Murray
Lydia Murray
RLRohan Lourie
Rohan Lourie
HTHui Tong
Hui Tong
YSYong H. Sheng
Yong H. Sheng
SPSumaira Zia PhD
Sumaira Zia PhD
Prolonged high fat diets (HFD) induce low-grade chronic intestinal inflammation in mice, and diets high in saturated fat are a risk factor for the development of human inflammatory bowel diseases. We hypothesized that HFD-induced endoplasmic reticulum (ER)/oxidative stress occur in intestinal secretory goblet cells, triggering inflammatory signaling and reducing synthesis/secretion of proteins that form the protective mucus barrier. In cultured intestinal cells non-esterified long-chain saturated fatty acids directly increased oxidative/ER stress leading to protein misfolding. A prolonged HFD elevated the intestinal inflammatory cytokine signature, alongside compromised mucosal barrier integrity with a decrease in goblet cell differentiation and Muc2, a loss in the tight junction protein, claudin-1 and increased serum endotoxin levels. In Winnie mice, that develop spontaneous colitis, HFD-feeding increased ER stress, further compromised the mucosal barrier and increased the severity of colitis. In obese mice IL-22 reduced ER/oxidative stress and improved the integrity of the mucosal barrier, and reversed microbial changes associated with obesity with an increase in Akkermansia muciniphila. Consistent with epidemiological studies, our experiments suggest that HFDs are likely to impair intestinal barrier function, particularly in early life, which partially involves direct effects of free-fatty acids on intestinal cells, and this can be reversed by IL-22 therapy.

1 April 2003 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
CSCosti D. Sifri
Costi D. Sifri
JBJakob Begun
Jakob Begun
FAFrederick M. Ausubel
Frederick M. Ausubel
SCStephen B. Calderwood
Stephen B. Calderwood
Staphylococcus aureus, an important pathogen of humans and other warm-blooded animals, is also capable of killing the nematodeCaenorhabditis elegans. Here, we show thatC. elegansorganisms that are fedS. aureusdie over the course of several days in a process that is correlated with the accumulation of bacteria within the nematode digestive tract. SeveralS. aureusvirulence determinants known or speculated to be important in mammalian pathogenesis, including the quorum-sensing global virulence regulatory systemagrand the global virulence regulatorsarA, the alternative sigma factor σB, alpha-hemolysin, and V8 serine protease, are required for full pathogenicity in nematodes. In addition, several definedC. elegansmutants were examined for susceptibility toS. aureusinfection. Enhanced susceptibility toS. aureuskilling was observed with loss-of-function mutations in theC. elegansgenesesp-2/sek-1andesp-8/nsy-1, which encode components of a conserved p38 MAP kinase signaling pathway involved in nematode defense against multiple pathogens. These results suggest that key aspects ofS. aureuspathogenesis have been conserved, irrespective of the host, and that specificC. eleganshost factors can alter susceptibility to this gram-positive human pathogen.

18 February 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ALAntonella de Luca
Antonella de Luca
SSSanne P. Smeekens
Sanne P. Smeekens
ACAndrea Casagrande
Andrea Casagrande
RIRossana Iannitti
Rossana Iannitti
KCKara L. Conway
Kara L. Conway
FVFrank van de Veerdonk
Frank van de Veerdonk
Patients with chronic granulomatous disease (CGD) have a mutated NADPH complex resulting in defective production of reactive oxygen species; these patients can develop severe colitis and are highly susceptible to invasive fungal infection. In NADPH oxidase-deficient mice, autophagy is defective but inflammasome activation is present despite lack of reactive oxygen species production. However, whether these processes are mutually regulated in CGD and whether defective autophagy is clinically relevant in patients with CGD is unknown. Here, we demonstrate that macrophages from CGD mice and blood monocytes from CGD patients display minimal recruitment of microtubule-associated protein 1 light chain 3 (LC3) to phagosomes. This defect in autophagy results in increased IL-1β release. Blocking IL-1 with the receptor antagonist (anakinra) decreases neutrophil recruitment and T helper 17 responses and protects CGD mice from colitis and also from invasive aspergillosis. In addition to decreased inflammasome activation, anakinra restored autophagy in CGD mice in vivo, with increased Aspergillus-induced LC3 recruitment and increased expression of autophagy genes. Anakinra also increased Aspergillus-induced LC3 recruitment from 23% to 51% (P < 0.01) in vitro in monocytes from CGD patients. The clinical relevance of these findings was assessed by treating CGD patients who had severe colitis with IL-1 receptor blockade using anakinra. Anakinra treatment resulted in a rapid and sustained improvement in colitis. Thus, inflammation in CGD is due to IL-1–dependent mechanisms, such as decreased autophagy and increased inflammasome activation, which are linked pathological conditions in CGD that can be restored by IL-1 receptor blockade. Significance Chronic granulomatous disease (CGD) has an immunodeficiency component and, in addition, an autoinflammatory component in which autophagy and inflammasome activation are linked and amenable to IL-1 blockade. This study provides a rationale to perform clinical trials to investigate the efficacy of blocking IL-1 in CGD colitis and expands the therapeutic potential of IL-1 antagonists to inflammatory diseases with defective autophagy.

1 November 2019 in Immunity
Verified
Journal Article
Closed access
MKMotoko Koyama
Motoko Koyama
PMPamela Mukhopadhyay
Pamela Mukhopadhyay
ISIona S. Schuster
Iona S. Schuster
AHAndrea S. Henden
Andrea S. Henden
JHJan Hülsdünker
Jan Hülsdünker
GHGeoffrey R. Hill
Geoffrey R. Hill

1 March 2005 in Trends in Microbiology
Verified
Journal Article
Closed access
CSCosti D. Sifri
Costi D. Sifri
JBJakob Begun
Jakob Begun
FAFrederick M. Ausubel
Frederick M. Ausubel